Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No credible adverse media (lawsuits, regulator action, misconduct or financial distress) involving Imprivata found in HSH's search of the last 24 months.
Data breaches, cyber incidents, regulator action and assurance status.
Jun 2026: Imprivata issued a security advisory for its Enterprise Access Management appliances covering several critical (up to CVSS 9.8) and high-severity flaws, with hotfixes for versions 24.2-26.1; it said there was no evidence of exploitation. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
Identity and access security software supplier; no regulatory or clinical safety actions found in the last 24 months.
Contract delivery, go-lives, terminations and disputes.
Nov 2025: NHS Wales Shared Services Partnership awarded a £100,577 contract (via reseller Softcat) for Imprivata OneSign subscriptions and support at Swansea Bay University Health Board. No troubled implementations or disputes found in HSH's search of the last 24 months.